First Phase 3 test of coronavirus vaccine candidate begins in US
An investigational vaccine developed by drugmaker Moderna and the National Institute of Allergy and Infectious Diseases began Phase 3 trials on Monday, becoming the first candidate to reach that step in testing.About 30,000 adult volunteers are...
Source: https://ift.tt/3jJjSpf
An investigational vaccine developed by drugmaker Moderna and the National Institute of Allergy and Infectious Diseases began Phase 3 trials on Monday, becoming the first candidate to reach that step in testing.About 30,000 adult volunteers are...
Source: https://ift.tt/3jJjSpf
0 Comments